FGFR2 and metabolic dysfunction-associated steatohepatitis: The expression of FGFR2 was found to be elevated in liver fibrosis patients with backgrounds of Hepatitis B infection (2.30-fold), alcohol abuse (1.60-fold), and non-alcoholic steatohepatitis (NASH, 2.03-fold) through a comparison with normal individuals.